Jump to content
  • Welcome!

    Register and log in easily with Twitter or Google accounts!

    Or simply create a new Huddle account. 

    Members receive fewer ads , access our dark theme, and the ability to join the discussion!

     

Hypothetical Question


Johnny Rockets

Recommended Posts

Something tells me Floppin will know the answer to this but...

Let's say hypothetically that there is a supplement that was recalled by the FDA about a year ago and is no longer on the market. Suddenly someone pops up on Amazon selling a case of the stuff. This is not illegal narcotics or anything just something that was a legit over the counter supplement that worked too well and was banned. Here are the questions I have:

1) Is that illegal?

2) If so, who can get in trouble for it? The person who purchases it, the seller, or both.

Not sure how FDA recalls work. Can a retailer or person just sell what they have in stock but not order anymore or does it have to be sent back?

Link to comment
Share on other sites

Determine the class level of the food recall. The way you handle the food recall will depend on the class level assigned by the FDA. Class I product recalls constitute a serious danger to human health if consumed. Class II foods may cause a mild health problem. Class III products don't pose any health danger and may simply violate labeling regulations.

It is illegal to sell any type of drug that has been banned by the FDA, but it's not illegal to sell any type of drug that hasn't been approved by the FDA. I don't know which particular drug you are talking about though.

Link to comment
Share on other sites

Determine the class level of the food recall. The way you handle the food recall will depend on the class level assigned by the FDA. Class I product recalls constitute a serious danger to human health if consumed. Class II foods may cause a mild health problem. Class III products don't pose any health danger and may simply violate labeling regulations.

It is illegal to sell any type of drug that has been banned by the FDA, but it's not illegal to sell any type of drug that hasn't been approved by the FDA. I don't know which particular drug you are talking about though.

Thanks...I don't think it is that big of a deal. There are news articles from a year ago that say it was recalled by the FDA but then they provide a link to the official FDA release and all it is is a warning not to take it and doesn't mention what Class it is. I know the places I used to buy it have all said for awhile that it was recalled and no longer available but it was odd to see it available through a seller on Amazon and didn't know how they could be selling it.

Link to comment
Share on other sites

Thanks...I don't think it is that big of a deal. There are news articles from a year ago that say it was recalled by the FDA but then they provide a link to the official FDA release and all it is is a warning not to take it and doesn't mention what Class it is. I know the places I used to buy it have all said for awhile that it was recalled and no longer available but it was odd to see it available through a seller on Amazon and didn't know how they could be selling it.

It sounds like it might not have actually been a recall, just an FDA recommendation. If that is the case then selling it is completely legal, however your more "reputable" vendors will not carry it based on the FDA recommendation for fear of potential lawsuits.

Here's an example of this.

On the heels of a warning from the U.S. Federal Drug Administration, the Call7 Investigators have found nasal Zicam products still on store shelves.

The FDA issued the warning letter to the makers of Zicam after the agency received more than 130 reports of loss of smell associated with the use of the over-the-counter product.

The Call7 Investigators were the first to uncover potential health problems with the cold remedy five years ago.

Call7 Investigator Theresa Marchetta checked Denver area stores to see if the Zicam products listed in the warning were still being sold and had no trouble finding them.

Walgreens spokesman Robert Elfinger told the Call7 Investigators that the company's stores pulled the Zicam nasal swabs and sprays from shelves yesterday.

He also said the products were flagged at the register so if a customer tried to purchase them, the cashier would be alerted and advise the customer not to make the purchase.

But when Marchetta visited a Denver area Walgreens, she found not only were the products still on store shelves, they were also on sale.

http://www.thedenverchannel.com/news/19782918/detail.html

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.


  • PMH4OWPW7JD2TDGWZKTOYL2T3E.jpg

  • Topics

  • Posts

    • It’s clear as day why we lost. The series best players were floridas. By 8 people before you get to Aho. And the worst 9 were all canes players. Worst being Orlov.       
    • For future reference, the good stuff ain't "white". If it's white it's cut to death. You're looking for pearly, almost shimmery looking chunks not powder. I used to be a wild motherfuger when I was young. LOL
    • gives a good update on the Saints salary cap situation.  While it gets better, but their dead money situtation is frightening, and will continue for another 2-3 seasons.   and this little excerpt about the Falcons is pretty much Falconing:   Some of the worst decisions franchises can make come when the team's incentives aren't aligned with the people who work for the team. Seven years removed from their last winning season and with a quarterback who has all of three career starts under center in Michael Penix Jr., the Falcons should not be all-in. There are reasons to be optimistic about what the future might hold, sure, but they were not one player away this offseason. General manager Terry Fontenot, though, might have been one player away from having a new job. After the disastrous, virtually inexplicable decision to guarantee Kirk Cousins $90 million in March 2024 and draft Penix a month later, and its natural conclusion with Cousins being benched by the end of his first year in Atlanta, the clock has been ticking on Fontenot's time with the Falcons. With the former Saints executive batting about 1-for-8 (Drake London) on his Day 1 and 2 picks in 2021 and 2022, it seems as if Atlanta is treading water. He is only the seventh GM since 2000 to start his career with four losing seasons and get a shot at turning things around in Year 5.     good summary on what we did, including this part " Carolina Panthers The superlative: Most likely to have definitely solved their problem this time, for sure Unlike the Falcons, the Panthers seem insistent on addressing their weak spot every single offseason. Since trading DJ Moore to the Bears as part of the deal for Bryce Young in 2023, Carolina has thrown asset after asset at wide receiver in an attempt to get its young quarterback some playmakers. Its moves for veterans have produced mixed results: Adam Thielen has been a reliably solid option and averaged a team-high 1.9 yards per route run over the past two seasons, but Diontae Johnson's brief run will probably be remembered only by obsessive Immaculate Grid users. The draft is where the Panthers have focused their efforts. After drafting Jonathan Mingo in 2023, Xavier Legette in 2024 and Tetairoa McMillan last month, they have invested top-40 picks on wide receivers in three consecutive drafts. They're the first team to do that in 20 years, but even they haven't gone to the heights that the 2003-05 Lions did: Detroit used three top-10 picks to add Charles Rogers, Roy Williams and Mike Williams. Two years later, the Lions added a fourth who stuck around slightly longer -- future Hall of Famer Calvin Johnson. The Lions went 1-for-3 at best with those three consecutive picks in the top 10. The Panthers are on pace to go 0-for-2. Mingo was dealt to the Cowboys before the end of his second season. Legette averaged a middling 1.3 yards per route run as a rookie, ranked 134th in ESPN's receiver score and generated 104 receiving yards below what an average receiver would have done with the same targets in 2024, per NFL Next Gen Stats, the 17th-worst mark in the league. It's perfectly reasonable to be patient with Legette and see what he can do in 2025, but it's also realistic to point out that he wasn't an impact player as a rookie. His most notable moment was dropping what would have potentially been a winning touchdown reception to beat the eventual Super Bowl champion Eagles. The Panthers will hope McMillan makes more of an instant impact. It's clear they're attempting to build a bully-ball group of receivers by adding Mingo (6-foot-2, 220 pounds), Legette (6-3, 227 pounds) and Jalen Coker (6-3, 213 pounds), an undrafted free agent who arguably outplayed Legette last season. At 6-4, McMillan is another big target for Young. At Arizona, McMillan was consistently able to leverage that frame into making tough catches. His massive catch radius and ability to create after bringing in the ball would be huge pluses for the Carolina offense if they translate quickly to the pro level.   https://www.espn.com/nfl/story/_/id/45318618/2025-nfl-offseason-nfc-teams-best-worst-deals-contracts-draft-picks-superlatives
×
×
  • Create New...